CAS Medical to Market, Sell Analogic's LIFEGARD Non-Invasive Patient Monitors

May 8, 2007 - Analogic Corp. and CAS Medical Systems Inc. announced today that they have signed an agreement granting worldwide exclusive rights to CAS Medical (CASMED) to market and sell Analogic's LIFEGARD family of non-invasive patient monitors.

The monitors will be co-branded with both the CASMED and Analogic names. Both companies intend to work together to develop additional monitors for the growing LIFEGARD family and for other specialty niche markets.

The LIFEGARD family includes the highly portable, versatile LIFEGARD I vital signs monitor targeting low-acuity areas; the LIFEGARD II measures ECG, HR, SpO2, NIBP, Temperature, Respiration, end-tidal CO2 and optional non-invasive cardiac output via Impedance Cardiography (ICG); the LIFEGARD ICG, a compact, stand-alone, non-invasive cardiac output and hemodynamic status monitor; and the LIFEGARD Vue Central Nurses' Station. The LIFEGARD family also includes the FETALGARD Lite Fetal Monitor, and the FETALGARD Lite - NIBP which measures maternal non-invasive blood pressure for monitoring Pregnancy-Induced Hypertension (PIH).

For more information on LIFEGARD Patient Monitors visit www.casmed.com/lifegard.